Courtesy: National Eye Institute, National Institutes of Health (NEI/NIH) A new study offers an explanation for how years of chronic sunlight exposure can increase the risk of cataract, a clouding of the eye lens that typically occurs with aging. The study firms up a link between the sun’s damaging rays and a process called oxidative [Read More]
News
Squalamine Eye Drops Under Study for Wet AMD
(Updated 4/17/16) On June 24, 2014, Ohr Pharmaceutical, Inc. announced positive top-line interim results for its Phase 2 clinical trial of Squalamine eye drops in patients with wet age-related macular degeneration (wet AMD). The data demonstrated a positive benefit in multiple visual function including a gain in visual acuity of +10.4 letters with Squalamine eye [Read More]
Omega-3 Inhibits Retinal Blood Vessel Growth
Researchers from Massachusetts Eye and Ear/Schepens Eye Research Institute, Harvard Medical School and other institutions have demonstrated for the first time that the omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), DHA and EPA, can inhibit choroidal neovascularization (CNV). Their findings will be published in PNAS Online Early Edition the week of June 16-20, 2014. “These are [Read More]
Stem Cell Trial for Myopic Macular Degeneration
Advanced Cell Technology (ACT) announced in a shareholders’ conference call on June 9, 2014, that it has initiated its myopic macular degeneration (MMD) trial at Jules Stein Eye Institute at UCLA. The open-label study will enroll 12 patients, with cohorts of 3 patients each in an ascending dosage format. As with it’s current trials for [Read More]
Blood Pressure Meds and AMD
by Dan Roberts A relationship has been found, but don’t throw away the meds. The media has recently been reporting research from the University of Wisconsin, which found an association between development of age-related macular degeneration (AMD) and use of blood pressure (BP) lowering medications. Before patients begin discarding their BP drugs, however, they should [Read More]